These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9080242)

  • 1. Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium.
    Kansanaho M; Olkkola KT
    Int J Clin Monit Comput; 1996 Nov; 13(4):217-24. PubMed ID: 9080242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
    Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
    Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intermediate acting muscle relaxants by infusion: the future.
    Mirakhur RK; McCourt KC; Kumar N
    Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hierarchical rule-based monitoring and fuzzy logic control for neuromuscular block.
    Shieh JS; Fan SZ; Chang LW; Liu CC
    J Clin Monit Comput; 2000; 16(8):583-92. PubMed ID: 12580234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rocuronium priming of atracurium-induced neuromuscular blockade: the use of short priming intervals.
    Abdulatif M; al-Ghamdi A; el-Sanabary M
    J Clin Anesth; 1996 Aug; 8(5):376-81. PubMed ID: 8832448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The duration of action of mivacurium is prolonged if preceded by atracurium or vecuronium.
    Rautoma P; Meretoja OA; Erkola O; Kalli I
    Acta Anaesthesiol Scand; 1995 Oct; 39(7):912-5. PubMed ID: 8848891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rocuronium- and mivacurium-induced neuromuscular block and intubating conditions: a comparison with vecuronium.
    van den Broek L; Hommes FD; Nap HJ; Wierda JM
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():27-30. PubMed ID: 8557002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of age on onset and recovery from atracurium, rocuronium and vecuronium blockade].
    de Almeida MC; Latorre F; Gervais HW; Kleeman PP
    Anaesthesist; 1996 Oct; 45(10):903-6. PubMed ID: 8992904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bolus plus continuous infusion protocol for controlling neuromuscular blockade during anesthesia.
    Botman JM; Arps H; Westenskow DR
    Int J Clin Monit Comput; 1995 May; 12(2):89-95. PubMed ID: 8847471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in myorelaxant therapy.
    Meakin GH
    Paediatr Anaesth; 2001; 11(5):523-31. PubMed ID: 11696115
    [No Abstract]   [Full Text] [Related]  

  • 15. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
    Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
    Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rocuronium is the best non-depolarizing relaxant to prevent succinylcholine fasciculations and myalgia.
    Martin R; Carrier J; Pirlet M; Claprood Y; Tétrault JP
    Can J Anaesth; 1998 Jun; 45(6):521-5. PubMed ID: 9669004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of recurarization during retransfusion of autologous blood withdrawn after injection of muscle relaxants: a comparison of rocuronium and mivacurium.
    Rohling RG; Rentsch KM; Beck-Schimmer B; Fuchs-Buder T
    J Clin Anesth; 2003 Mar; 15(2):85-90. PubMed ID: 12719045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intubating conditions and onset of action after rocuronium, vecuronium, and atracurium in young children.
    Scheiber G; Ribeiro FC; Marichal A; Bredendiek M; Renzing K
    Anesth Analg; 1996 Aug; 83(2):320-4. PubMed ID: 8694312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The onset of rocuronium, but not of vecuronium or mivacurium, is modified by tourniquet inflation.
    Audibert G; Donati F
    Anesth Analg; 1996 Apr; 82(4):848-53. PubMed ID: 8615509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.